Biotech Inscript

About Publications Sign in Subscribe

News

Stay Informed and Updated

Syncona's New Venture Beacon Therapeutics Set to Revolutionise Gene Therapy Landscape

12 June 2023: Syncona Ltd has introduced its third gene therapy company Beacon Therapeutics Holdings Ltd. Beacon Therapeutics will bring together two preclinical ophthalmologic programs owned by Syncona with Applied Genetic Technologies Corp's (AGTC's) advanced X-linked retinitis pigmentosa (XLRP) program. Syncona has allocated £75 million to Beacon, which includes the

VaxEquity Awarded A £700k UK Grant to Boost RNA Manufacturing Capacity

5 June 2023: RNA vaccine developer VaxEquity, in partnership with the Centre for Process Innovation (CPI), has successfully obtained a £700k grant from Innovate UK, an innovation agency based in the UK. This substantial funding will support a joint initiative aimed at progressing the manufacturing methods for RNA vaccines and

Samsung Biologics Enters Into Major Manufacturing Contract Worth $400 Million+ With Pfizer

June 8, 2023: South Korea-based Samsung Biologics has secured a lucrative contract worth $411 million from pharmaceutical powerhouse Pfizer to produce biosimilars for it. As part of this agreement, Samsung will provide increased manufacturing capabilities to accommodate the production of a diverse range of biosimilars, including those related to oncology,

UK’s Revolutionary Intracellular Drug Delivery Centre To Facilitate RNA Development

01 June 2023: A novel intracellular drug delivery centre is set to be established in the United Kingdom with the aim of providing extensive support for the advancement of ribonucleic acid (RNA) vaccines and therapeutics, as well as facilitating the progress of innovative drug delivery technologies. The UK intracellular drug

3M Pledges Nearly £120 Million Investment in Biopharma Filtration Technology Advancements

31 May, 2023: 3M, a company known for its expertise in industrial equipment manufacturing, intends to allocate £120 million to enhance its capacities in order to provide greater assistance to the rapidly expanding field of biotech manufacturing. The investment will involve enhancing facilities and equipment, along with the establishment of

Exploring The Major MedTech Trends Reshaping The Global Healthcare System

In the vast realm of healthcare, technology has emerged as a driving force, catalysing the greatest breakthroughs and transforming the way we prevent, diagnose, and treat diseases. With each passing year, innovations in medical technology continue to push the boundaries of what was once considered unimaginable. From artificial intelligence to

UK Government Pledges £650m 'Life Sci for Growth' Fund to Supercharge Life Sciences Industry

25 May 2023: Jeremy Hunt, Chancellor of the Exchequer (Chief finance minister) has revealed the UK Government's plan to allocate a £650 million fund, aimed at propelling the growth and progress of the country's life sciences industry. The package has been portrayed as a substantial reserve of resources intended to

Top Stories

Roche to Acquire Carmot Therapeutics in a $3.1 Billion Deal

Roche to Acquire Carmot Therapeutics in a $3.1 Billion Deal

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Samsung Biologics and VC Firm Kurma Partners Announce Biologics Manufacturing Partnership for Kurma's Portfolio Companies

Edesa Biotech Secures C$23 Million Canadian Govt. Funding to Accelerate Breakthrough Immune Treatment

Edesa Biotech Secures C$23 Million Canadian Govt. Funding to Accelerate Breakthrough Immune Treatment